J. Goldman & Co’s PetMed Express PETS Stock Holding History

J. Goldman & Co’s Portfolio PETS Stock Details PETS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-900,000	Closed	-$4.34M	–	592
2024 Q4	$4.34M	Buy	+900,000	New	+$4.22M	0.11%	202
2024 Q1	–	Sell	-9,700	Closed	-$73.3K	–	494
2023 Q4	$73.3K	Sell	9,700 -219,000	-96%	-$1.8M	﹤0.01%	315
2023 Q3	$2.34M	Sell	228,700 -110,600	-33%	-$1.36M	0.08%	189
2023 Q2	$4.68M	Buy	339,300 +331,800	+4,424%	+$4.98M	0.17%	143
2023 Q1	$122K	Buy	+7,500	New	+$141K	﹤0.01%	327
2022 Q3	–	Sell	-763,400	Closed	-$15.2M	–	464
2022 Q2	$15.2M	Buy	763,400 +463,400	+154%	+$10.4M	0.74%	31
2022 Q1	$7.74M	Sell	300,000 -195,000	-39%	-$5.06M	0.35%	84
2021 Q4	$12.5M	Sell	495,000 -290,900	-37%	-$8.05M	0.69%	34
2021 Q3	$21.1M	Buy	785,900 +334,400	+74%	+$9.63M	1.06%	14
2021 Q2	$14.4M	Buy	+451,500	New	+$14.3M	0.56%	42
2020 Q1	–	Sell	-100,000	Closed	-$2.35M	–	320
2019 Q4	$2.35M	Buy	100,000 +50,000	+100%	+$1.12M	0.17%	125
2019 Q3	$901K	Buy	+50,000	New	+$826K	0.07%	189
2019 Q2	–	Sell	-33,500	Closed	-$763K	–	327
2019 Q1	$763K	Buy	+33,500	New	+$755K	0.04%	215

Other funds holding PETS

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

OCMI

Oaktop Capital Management II Chatham, New Jersey $1.34B AUM 114.5% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

J. Goldman & Co's PETS Position: Q1 2025 in Review

J. Goldman & Co sold out of PetMed Express (PETS) in Q1 2025, closing a stake of 72,000 shares — an estimated $347K sold.

J. Goldman & Co first reported a position in PETS in Q3 2021 and held it in 2 quarters. The position peaked at $347K in Q4 2024. 72 funds tracked by Wall St. Rank hold PETS as of Q1 2025.

J. Goldman & Co reported no remaining PetMed Express position as of Q1 2025 after selling out during the quarter.
J. Goldman & Co sold 72,000 PetMed Express shares in Q1 2025, an estimated $347K.
J. Goldman & Co first reported a position in PetMed Express in Q3 2021 and held it in 2 quarters.
J. Goldman & Co's PetMed Express position peaked at $347K in Q4 2024.
72 funds tracked by Wall St. Rank held PetMed Express as of Q1 2025.

Based on J. Goldman & Co's 13F filing for Q1 2025, filed 15 May 2025.